(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 9. Cellular effects of Shh manipulations. (A) KAAD/Fgf2-treated eyes show a
significantly increased number of Brn3a-positive ganglion cells compared with
Fgf2-treated eyes (P<0.001). This corresponds to a 23.09% increase
in the number of ganglion cells. Rcas-Shh/Fgf2-treated eyes have a
significantly lower number of ganglion cells (P<0.001) than
Fgf2-treated controls, corresponding to a 42.98% decrease in the number of
ganglion cells. (B) Rcas-Shh/Fgf2-treated eyes show increased cell death
throughout the retina when compared with Fgf2 (P<0.001) and
KAAD/Fgf2-treated eyes. There is no significant difference between KAAD/Fgf2
eyes and Fgf2-treated eyes. (C) Rcas-Shh/Fgf2-treated eyes also show increased
cell death in the presumptive ganglion cell layer, compared with Fgf2-treated
controls P<0.001). There is no statistically significant
difference in cell death between KAAD/Fgf2-treated eyes and Fgf2-treated eyes.
* denotes statistical significance. Error bars shown are s.e.m.